SURMODICS INC — Director's Dealing 2018

Jun 13, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2018-06-11

Reporting Person: OLSON CHARLES W (Senior VP of Bus Dev, Med Dev)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-11	Common Stock	M	4280	$23.95	Acquired	39955	Direct
2018-06-11	Common Stock	M	9963	$20.25	Acquired	49918	Direct
2018-06-11	Common Stock	F	9484	$55.40	Disposed	40434	Direct
2018-06-11	Common Stock	S	10000	$55.002	Disposed	30434	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-11	Employee Stock Option (right to buy)	$23.95	M	4280	Disposed	2023-11-30	Common Stock (4280)	Direct
2018-06-11	Employee Stock Option (right to buy)	$20.25	M	9963	Disposed	2022-12-17	Common Stock (9963)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	800	Indirect

Footnotes

F1: The reporting person makes a payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3.

F2: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018.

F3: Reflects the weighted average price of 10,000 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on June 11, 2018 with sale prices ranging from $55.00 to $55.05 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F4: The award vests in four equal installments on each of the first four anniversaries of the November 30, 2016 grant date.

F5: The award vests in four equal installments on each of the first four anniversaries of the December 17, 2015 grant date.